EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study.
Kausik K RayBart MolemansW Marieke SchoonenPeriklis GiovasSarah BrayGaia KiruJennifer MurphyMaciej BanachStefano De ServiDan GaitaIoanna Gouni-BertholdG Kees HovinghJacek J JozwiakJ Wouter JukemaRobert Gabor KissSerge KownatorHelle K IversenVincent MaherLuis MasanaAlexander ParkhomenkoAndré PeetersPiers CliffordKatarina RaslovaPeter SiostrzonekStefano RomeoDimitrios TousoulisCharalambos VlachopoulosMichal VrablikAlberico L CatapanoNeil R Poulternull nullPublished in: European journal of preventive cardiology (2022)
Gaps between clinical guidelines and clinical practice for lipid management across Europe persist, which will be exacerbated by the 2019 guidelines. Even with optimized statins, greater utilization of non-statin LLT is likely needed to reduce these gaps for patients at highest risk.